RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes
AUTOR(ES)
Jiang, Hongping
FONTE
The National Academy of Sciences
RESUMO
Human melanoma cells growth-arrest irreversibly and terminally differentiate on treatment with a combination of fibroblast interferon and the protein kinase C activator mezerein. This experimental protocol also results in a loss of tumorigenic potential and profound changes in gene expression. Various cloning and cDNA microarray strategies are being used to determine the complete spectrum of gene expression changes underlying these alterations in human melanoma cells. An efficient approach, Rapid Subtraction Hybridization (RaSH), has been developed that is permitting the identification of genes of potential relevance to cancer growth control and terminal cell differentiation. RaSH cDNA libraries are prepared from double-stranded cDNAs that are enzymatically digested into small fragments, ligated to adapters, and PCR amplified followed by incubation of tester and driver PCR fragments. This subtraction hybridization scheme is technically simple and results in the identification of a high proportion of differentially expressed sequences, including known genes and those not described in current DNA databases. The RaSH approach represents an efficient methodology for identifying and cloning genes displaying differential expression that associate with and potentially regulate complex biological processes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18824Documentos Relacionados
- Reciprocal subtraction differential RNA display: An efficient and rapid procedure for isolating differentially expressed gene sequences
- Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes.
- Skin rash, dyspnea and bone pain: secondary syphilis
- A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes.
- Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.